Filing metadata

Accession number
0001140361-21-032105
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Sep 22, 2021
Reporting period
Sep 20, 2021
Description
Insider transaction

Explore SEC Filings Hub